+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new butadiene derivative, T-686, inhibits plasminogen activator inhibitor type-1 production in vitro by cultured human vascular endothelial cells and development of atherosclerotic lesions in vivo in rabbits



A new butadiene derivative, T-686, inhibits plasminogen activator inhibitor type-1 production in vitro by cultured human vascular endothelial cells and development of atherosclerotic lesions in vivo in rabbits



Thrombosis Research 85(4): 305-314



Plasminogen activator inhibitor-1 (PAI-1), the major physiologic inhibitor of tissue-type plasminogen activator and urokinase, is abundantly expressed in atherosclerotic vascular wall. To determine the role of PAI-1 in vascular wall, we have used a novel inhibitor of PAI-1, (3E, 4E)-3-benzylidene-4-(3,4,5-trimethoxy-benzylidene) -pyrrolidine-2,5-dione (T-686). T-686 was given to human vascular endothelial cells in vitro and to rabbits subjected to high cholesterol diet and mechanical injury in vivo. T-686 attenuated the augmentation of PAI-1 antigen accumulation induced by transforming growth factor beta in conditioned medium from the human umbilical vein endothelial cells. In rabbits with aortic atherosclerosis induced by hypercholesterolemia and implantation of indwelling plastic tubing, oral administration of T-686 (30mg/kg body weight/day) for 8 weeks attenuated the increase in plasma PAI-1 activity induced by vascular injury without decreasing blood triglyceride and cholesterol. This was accompanied by the reduction in aortic PAI-1 mRNA expression and the inhibition of development of atherosclerosis lesions. Thus, T-686 not only decreased PAI-1 synthesis in vascular cells in vitro but also protected against the development of vascular lesions in vivo. This compound may be useful in defining the role of PAI-1 in atherothrombotic states.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045079149

Download citation: RISBibTeXText

PMID: 9062954

DOI: 10.1016/s0049-3848(97)00016-9


Related references

Effect of etofibrate and nicanartine on plasminogen activator inhibitor type-1 production in vitro by cultured vascular cells and on plasma plasminogen activator inhibitor type-1 activity in vivo in rabbits. Current Therapeutic Research. 57(3): 202, 1996

Inhibitory effect of a new butadiene derivative on the production of plasminogen activator inhibitor-1 in cultured bovine endothelial cells. Journal of Biochemistry 120(6): 1203-1208, 1996

Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. Thrombosis and Haemostasis 84(1): 59-64, 2000

Hypothermia stimulates plasminogen activator inhibitor type-1 and tissue-type plasminogen activator expression in cultured human umbilical vein endothelial cells in vitro. Fibrinolysis 10(SUPPL 3): 141, 1996

Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thrombosis Research 74(2): 163-168, 1994

The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. Journal of Cell Biology 110(1): 155-163, 1990

Effects of baicalein isolated from roots of Scutellaria baicalensis Georgi on interleukin 1 beta - and tumour necrosis factor alpha -induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 production in cultured human umbilical vein endothelial cells. Phytotherapy Research 11(5): 363-367, 1997

Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. Journal of Pharmacy and Pharmacology 49(8): 816-822, 1997

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia 44(6): 713-720, 2001

Transcription factor decoy ODN for activator protein-1 inhibits expression of type 1 plasminogen activator inhibitor gene induced by high glucose and angiotensin II in cultured human vascular smooth muscle cells. Diabetes 50(Supplement 2): A246, 2001

Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thrombosis and Haemostasis 70(3): 469-474, 1993

The effect of glycosaminoglycans on tissue plasminogen activator and plasminogen activator inhibitor production by cultured human umbilical vein endothelial cells. Journal of Physiology (Cambridge) 423: 80P, 1990

Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Arteriosclerosis and Thrombosis 14(7): 1040-1046, 1994

Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. Journal of Laboratory and Clinical Medicine 109(1): 97-104, 1987

Secretion of tissue type plasminogen activator and plasminogen activator inhibitor by cultured human retinal endothelial cells modulation by insulin like growth factor. Investigative Ophthalmology & Visual Science 30(3 SUPPL): 465, 1989